CAS No.1961-77-9,CHLORMADINON Suppliers

Products Categories

Pharmaceutical (30)
Organic Chemicals (9)
Others (2)
Reagent (1)
Materials (1)

Basic Information

Molecular Structure:
CAS No.:	1961-77-9
Name:	CHLORMADINON
Article Data:	9

Formula:	C21H27 Cl O3
Molecular Weight:	362.897
Synonyms:	6-Chloro-6-dehydro-17-hydroxyprogesterone;6-Chloro-6-dehydro-17a-hydroxyprogesterone;Chlormadinon;Chlormadinone;
EINECS:	217-802-3
Density:	1.24 g/cm³
Melting Point:	213°C
Boiling Point:	506.7 °C at 760 mmHg
Flash Point:	260.2 °C
Safety:	Human reproductive effects by ingestion: changes in the uterus, cervix, vagina, and female fertility. An experimental teratogen. Other experimental reproductive effects. When heated to decomposition it emits toxic fumes of Cl⁻.
PSA:	54.37000
LogP:	4.18090

Total:38 Page 1 of 1 1

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1961-77-9

Chemistry

drug name : chlorine to progesterone
English : Chlormadinone
AcetateFormula :C₂₁H₂₇ClO₃
Mol. mass :362.89 g/mol

Uses

Indications : k potent oral progesterone, not estrogen and androgen activity. Anti ovulation Norethisterone role of 18.4 times, and long-term estrogen propargyl ether estrogen component compatibility estrogen compound propargyl ether films, as long-acting oral contraceptives, a meeting of medication, on the 25th of contraception, such as increased Norethisterone A formation of a new "triple propargyl ether estrogen tablets," better clinical results.

Standards and Recommendations

Ether compound ACETYLENE estrogen tablets (long-acting contraceptive tablets 1) per unit to CHLORINE mg PROGESTERONE and estrogen propargyl ether 0.0083mg. Triple propargyl ether estrogen tablets : Each tablet contains 65 mg of megestrol acetate, and 65 mg Norethisterone A female propargyl ether 2mg.

Specification

Note :
1. Beginning nausea, vomiting, dizziness, weakness, loss of appetite, increased leucorrhea, breasts bulging other adverse reactions, but with the time taken to extend or reduce the symptoms disappear. Individual or by the increase in the volume of short-term amenorrhea.

2. Long-term medication, a few have hypertension and mild changes in glucose metabolism, hypertension and therefore had a history of diabetes patients with caution.

3. Liver disease, nephritis, uterine fibroids, breast lumps, breast-feeding women hanged.

4. If the medication two cycles, menstrual not ebb, withdrawal, and to exclude the possibility of pregnancy.